Inovio to participate in virtual fireside chat on the potential treatment of recurrent respiratory papillomatosis with key opinion leader

Fireside chat, moderated by hartaj singh of oppenheimer & co., will be held on wednesday, january 24, 2024,  at 12:00pm et plymouth meeting, pa. , jan. 22, 2024 /prnewswire/ -- inovio (nasdaq: ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from hpv-associated diseases, cancer and infectious diseases, today announced that it will participate in a virtual fireside chat on the potential treatment of recurrent respiratory papillomatosis (rrp).
INO Ratings Summary
INO Quant Ranking